BioSpace News Archive

Biosenta Announces Debt Settlement

Biosenta Inc. (CSE: ZRO) (“Biosenta” or the “Company”), announces that it intends to enter into debt settlement agreements (the “Agreements”)

January 31, 2024
·
7 min read
Biotech Beach

Tarsus to Participate in Fireside Chat at the Sixth Annual Guggenheim Healthcare Talks Conference

Tarsus Pharmaceuticals, Inc. announced that Bobak Azamian, M.D., Ph.D., Chief Executive Officer and Chairman, will participate in an in-person fireside chat at the Sixth Annual Guggenheim Healthcare Talks conference in New York City at 1:00 p.m. ET on Thursday, February 8, 2024.

January 31, 2024
·
1 min read
Drug Development

Intellia Therapeutics Announces Publication of Positive Interim Phase 1 Data for NTLA-2002 in Patients with Hereditary Angioedema in the New England Journal of Medicine

Intellia Therapeutics, Inc. announced that interim results from the Phase 1 portion of the Phase 1/2 study of NTLA-2002 were published online in the New England Journal of Medicine.

January 31, 2024
·
7 min read
Nicox Receives Confirmation of 5-year Patent Term Extension of U.S. Patent for Latanoprostene Bunod, Commercialized as VYZULTA®

Nicox SA announced that the United States Patent and Trademark Office (USPTO) has determined that U.S. Patent No. 7,629,345, which covers latanoprostene bunod, commercialized by Bausch + Lomb under the trademark VYZULTA®, is eligible for patent term extension of five years.

January 31, 2024
·
4 min read
AlzeCure CEO Martin Jönsson to Present at the International Investor Conference BioCapitalEurope

AlzeCure Pharma AB announced that its CEO Martin Jönsson will present the company at the investor conference BioCapitalEurope 2024, which is organized by EQT Life Sciences.

January 31, 2024
·
2 min read
Drug Development

MetrioPharm Publishes First Trial Data Showing Effects of Host-Directed Therapy in COVID-19

MetrioPharm AG announced that results from its clinical trial CT-05 in hospitalized patients with moderate to severe COVID-19 have been published in the renowned journal The Lancet Regional Health – Europe.

January 31, 2024
·
6 min read
FDA

Boston Scientific Receives FDA Approval for FARAPULSE™ Pulsed Field Ablation System

Boston Scientific Corporation (NYSE: BSX) announced it has received U.S. Food and Drug Administration (FDA) approval for the FARAPULSE™ Pulsed Field Ablation (PFA) System.

January 31, 2024
·
7 min read
Business

Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2023 Results

Thermo Fisher Scientific Inc., the world leader in serving science, reported its financial results for the fourth quarter and full year ended December 31, 2023.

January 31, 2024
·
28 min read
InspireMD Receives CE Mark Recertification Under EU’s New Medical Device Regulation (MDR) Regulatory Framework

InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Carotid Stent System (EPS) for the prevention of stroke, today announced that it has received CE Mark recertification under the European Union’s new Medical Device Regulation (MDR) regulatory framework.

January 31, 2024
·
5 min read
Genetown

Tango Therapeutics to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference

Tango Therapeutics, Inc. announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference on Wednesday, February 7, 2024 at 11:30 AM EST.

January 31, 2024
·
1 min read